The current valuation score of Can Fite Biopharma Ltd is 7.35, ranking 109 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.00, which is -239366.67% below the recent high of 4.31 and -33779911.11% above the recent low of -608.04.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.